A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.
about
The importance of relative standards in ADHD diagnoses: evidence based on exact birth datesChanges in behavior as side effects in methylphenidate treatment: review of the literatureA review of long-acting medications for ADHD in CanadaCost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidateExtended-release medications for children and adolescents with attention-deficit hyperactivity disorderTreating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulantsComparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.The Amygdala's Neurochemical Ratios after 12 Weeks Administration of 20 mg Long-acting Methylphenidate in Children with Attention Deficit and Hyperactivity Disorder: A Pilot Study Using (1)H Magnetic Resonance Spectroscopy.Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers.Parent experiences questionnaire for outpatient child and adolescent mental health services (PEQ-CAMHS Outpatients): reliability and validity following a national surveyWhat contributes to patient and parent satisfaction with medication in the treatment of children with ADHD? A report on the development of a new rating scale.The role of galenic innovation in improving treatment compliance and persistence: three case studies.Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysisRemission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate.The NICE ADHD health technology assessment: a review and critiqueEffectiveness and safety of methylphenidate and atomoxetine for attention deficit hyperactivity disorder: a systematic reviewSwitching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): A Multi-center, Open-label Study in Korea.Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA studyAn Open-label, Self-control, Prospective Study on Cognitive Function, Academic Performance, and Tolerability of Osmotic-release Oral System Methylphenidate in Children with Attention-deficit Hyperactivity Disorder.Efficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use.Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysisEffects of maternal symptom ratings and other clinical features on short-term treatment response to OROS methylphenidate in children and adolescents with ADHD in a naturalistic clinical setting.Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacyEnhancing ADHD medication adherence: challenges and opportunitiesComparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison.Effect of Ferritin on Short-Term Treatment Response in Attention Deficit Hyperactivity Disorder.Les médicaments à libération prolongée pour les enfants et les adolescents ayant un trouble de déficit de l’attention avec hyperactivité.Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
P2860
Q22252388-B7C32170-A406-4421-A87B-EDFBFDA49FC9Q28078623-EAA8C517-6908-4FA5-A01F-1927769A71A7Q28263326-3CD49F55-DD4C-49C0-9296-0F88661BCB06Q28547634-1B1A6994-08B3-4BEA-85D3-5B7142C59B72Q33588902-82387B32-2B3B-44E4-9F50-8A78CBBB1A5DQ33746664-69FDAD58-60CF-46C3-999F-EDD197FBDC39Q34072167-28EB61FE-61E5-47D4-B745-998C11640E19Q34129852-5C674BE6-0CC6-4A60-B7C8-1D30CC393721Q34421050-F313568A-A332-42AD-83FB-F88EFC4100FDQ34719368-4DC41D10-16AB-48DA-8A26-8A77E6715531Q35061463-42757B41-EE5F-4700-A466-ABBC48BAFB26Q35233590-AB3EBC2D-AD49-4633-92C5-18EB6197417BQ35454381-30CF8BFA-940F-44BD-B6CA-AFF3340DB21FQ35576553-52154E86-1E56-427B-B60F-542C598B419AQ36026845-DFCA8008-A8CD-42E5-BBB7-337E24B9A556Q36491460-6AC083C9-999D-4A64-959C-52857F08057AQ36508048-71FF141C-941B-46C8-B0EB-CFB44BA851DBQ36599218-2245FDA5-3E0D-4FB3-B34C-A017CE5314A6Q36613827-93FC1DAA-33E7-46AF-A759-B4D856C01A93Q36695980-361EA629-7783-4D45-B468-1C27C4A288D5Q36923591-B28442C2-E0D5-43DF-8CCC-6CDE44BFB44EQ36983210-753D9082-00F4-4B5E-B420-24D68E8DB60BQ37334076-9CC36930-100B-4583-B5B8-A60BB259819AQ38090466-3E44DC85-7A00-40D9-99CC-4422429B272DQ38109853-E6846965-EEB0-4697-9A40-02B010F6BBFCQ38930427-9304ADAE-20CB-48ED-8B1E-2E7F10CEFBDCQ41341572-1BC2868B-4AEA-4B5F-9502-6CEA69C7BA73Q47322558-B8543D0B-D2B7-455C-9F01-4642453B5834Q58698663-AB58A517-A15A-49AB-A1AD-C53F175B2E4E
P2860
A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A randomized, controlled effec ...... eficit-hyperactivity disorder.
@ast
A randomized, controlled effec ...... eficit-hyperactivity disorder.
@en
type
label
A randomized, controlled effec ...... eficit-hyperactivity disorder.
@ast
A randomized, controlled effec ...... eficit-hyperactivity disorder.
@en
prefLabel
A randomized, controlled effec ...... eficit-hyperactivity disorder.
@ast
A randomized, controlled effec ...... eficit-hyperactivity disorder.
@en
P2093
P1476
A randomized, controlled effec ...... eficit-hyperactivity disorder.
@en
P2093
Carin E Binder
James Swanson
Jenny Wang
Margaret Steele
Margaret Weiss
Rosanna S Prinzo
P304
P577
2006-01-23T00:00:00Z